Visiun® Develops Reporting to Analyze COVID-19 Antibody Titers for Plasma Donation Eligibility
Visiun, the leader in laboratory analytics, has developed new reporting that analyzes COVID-19 antibody titers for plasma donation enabling health systems to identify what percentage of their tested population meet donation eligibility.
ANN ARBOR, Mich., May 4, 2020 /PRNewswire-PRWeb/ -- Visiun, the leader in laboratory analytics, has developed new reporting that analyzes COVID-19 antibody titers for plasma donation enabling health systems to identify what percentage of their tested population meet donation eligibility.
Developed in quick response to address a critical customer request, these new analytics provide a breakdown from positive COVID-19 patients carrying enough of the antibody to be eligible for plasma donation. This includes the number of positive and negative antibody test results derived from the number of samples tested as well as a categorization of the amount of antibody titration levels using defined markers for donor eligibility thresholds. Hospitals can see the percentages of samples that meet each defined threshold for plasma donation eligibility criteria.
Convalescent plasma is the liquid part of blood that is collected from patients who have recovered from the novel coronavirus disease, COVID-19, caused by the virus SARS-COV-2. According to the USFDA, COVID-19 patients develop antibodies in the blood against the virus. Convalescent plasma is currently being investigated for the treatment of COVID-19 because there is no approved treatment for this disease and there is some information that suggests it might help some patients recover from COVID-19.
In addition to these new analytics, Visiun has been proactively helping laboratories respond to the COVID-19 pandemic with the creation of a suite of applicable analytics, offered at no charge to laboratories that have Visiun's software product, Performance Insight®, installed. Additional capabilities include reporting for laboratories to monitor volumes of positive and negative test results by laboratory location, reporting that filters new positive cases from repeat positive results, and the ability to distinguish high volume COVID-19 positive areas based on zip codes. Importantly, this tool can also be used for laboratories to monitor their COVID-19 test turnaround times and trending volumes.
Compatible with every major LIS on the market, Performance Insight provides laboratory management with business intelligence and analytics to help their teams monitor key service commitments and improve workflow, quality, and financial performance. With Performance Insight, laboratories can eliminate manual reporting processes and see everything that is happening in the lab on a daily basis including turnaround time, quality, productivity/workflow, blood product utilization, test utilization, and more.
About Visiun, Inc.
Visiun® is the leading provider of performance analytics to the laboratory industry. Headquartered in Ann Arbor, Michigan, Visiun has been providing services to the laboratory industry for over ten years, with hundreds of laboratories installed across the United States. Performance Insight®, Visiun's core product, provides laboratory managers with a comprehensive suite of analytics that deliver immediate improvements in performance, efficiency, and quality. For more information, please visit http://www.visiun.com.
SOURCE Visiun, Inc.
Share this article